Prudential Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
+3,380
New +$192K ﹤0.01% 2182
2026
Q1
Sell
-6,570
Closed -$854K 2520
2025
Q4
$854K Sell
6,570
-6,980
-52% -$958K ﹤0.01% 1653
2025
Q3
$1.46M Sell
13,550
-14,570
-52% -$1.59M ﹤0.01% 1503
2025
Q2
$2.6M Sell
28,120
-44,738
-61% -$3.51M ﹤0.01% 1254
2025
Q1
$6.45M Sell
72,858
-30,417
-29% -$2.64M 0.01% 739
2024
Q4
$7.94M Buy
+103,275
New +$7.21M 0.01% 698
2024
Q1
Sell
-13,200
Closed -$36.3K 2767
2023
Q4
$36.3K Buy
+13,200
New +$30.7K ﹤0.01% 2580

Other funds holding WGS

Prudential Financial's WGS Position: Q2 2026 in Review

Prudential Financial opened a new position in GeneDx Holdings (WGS) in Q2 2026: 3,380 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #2182 among its holdings. This is a return to the name: Prudential Financial previously reported a position in WGS as recently as Q4 2025.

Prudential Financial first reported a position in WGS in Q4 2023 and has held it in 7 quarters since. The position peaked at $7.94M in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Prudential Financial held 3,380 shares of GeneDx Holdings worth $232K as of Q2 2026.
  • GeneDx Holdings was a new Prudential Financial position in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2182 holding.
  • Prudential Financial first reported a position in GeneDx Holdings in Q4 2023 and has held it in 7 quarters since.
  • Prudential Financial's GeneDx Holdings position peaked at $7.94M in Q4 2024.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.